Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;73 Suppl 1(Suppl 1):4-13.
doi: 10.1002/hep.31288. Epub 2020 Nov 24.

Epidemiology of Hepatocellular Carcinoma

Katherine A McGlynn  1 , Jessica L Petrick  2 , Hashem B El-Serag  3
Affiliations
Review

Epidemiology of Hepatocellular Carcinoma

Katherine A McGlynn et al. Hepatology. 2021 Jan.

Abstract

Liver cancer is a major contributor to the worldwide cancer burden. Incidence rates of this disease have increased in many countries in recent decades. As the principal histologic type of liver cancer, hepatocellular carcinoma (HCC) accounts for the great majority of liver cancer diagnoses and deaths. Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain, at present, the most important global risk factors for HCC, but their importance will likely decline in the coming years. The effect of HBV vaccination of newborns, already seen in young adults in some countries, will be more notable as vaccinated cohorts age. In addition, effective treatments for chronic infections with both HBV and HCV should contribute to declines in the rates of viral-associated HCC. Unfortunately, the prevalence of metabolic risk factors for HCC, including metabolic syndrome, obesity, type II diabetes and non-alcoholic fatty liver disease (NAFLD) are increasing and may jointly become the major cause of HCC globally. Excessive alcohol consumption also remains an intractable risk factor, as does aflatoxin contamination of food crops in some parts of the world. While significant efforts in early diagnosis and better treatment are certainly needed for HCC, primary prevention efforts aimed at decreasing the prevalence of obesity and diabetes and controlling mycotoxin growth, are just as urgently required.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Global age-adjusted incidence rates of liver cancer, estimated for 2018. Data source: GLOBOCAN 2018. Graph production: IARC (http://gco.iarc.fr/today), World Health Organization.
Figure 2.
Figure 2.
Trends in hepatocellular carcinoma incidence rates by country, 1978–1982 through 2008–2012. Rates are per 100,000 person-years and age-adjusted to the world standard population.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. - PubMed
    1. Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, Ferlay J, et al. International trends in hepatocellular carcinoma incidence, 1978–2012. Int J Cancer 2019;E-pub (Oct 10). - PMC - PubMed
    1. Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology 2018;67:600–611. - PMC - PubMed
    1. Petrick JL, Florio AA, Loomba R, McGlynn KA. Have incidence rates of liver cancer in the U.S. peaked? Cancer 2020. - PMC - PubMed
    1. Zhang X, El-Serag HB, Thrift AP. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Cancer Epidemiol Biomarkers Prev 2020;29:88–94. - PubMed

MeSH terms